Bevacizumab-induced pityriasis rubra pilaris-like eruption.

We present a 70-year-old man who developed erythroderma both clinically and histologically consistent with pityriasis rubra pilaris 10 days after intravitreal injection of bevacizumab for age-related macular degeneration. As immune-modulating drugs grow in their application for a host of diseases, recognition of associated medication complications is important. PMID: 27365893 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/27365893?dopt=Abstract

Source: Baylor University Medical Center Proceedings - June 30, 2016 Category: Universities & Medical Training Authors: Brown S, Fletcher JW, Fiala KH Tags: Proc (Bayl Univ Med Cent) Source Type: research